cimetidine has been researched along with Cancer of Duodenum in 6 studies
Cimetidine: A histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output.
cimetidine : A member of the class of guanidines that consists of guanidine carrying a methyl substituent at position 1, a cyano group at position 2 and a 2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl group at position 3. It is a H2-receptor antagonist that inhibits the production of acid in stomach.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Thirteen patients with Zollinger-Ellison syndrome (ZES) were treated with cimetidine." | 7.66 | Cimetidine treatment of acute and chronic Zollinger-Ellison syndrome. ( Bonfils, S; Gratton, J; Mignon, M, 1979) |
| "Thirteen patients with Zollinger-Ellison syndrome (ZES) were treated with cimetidine." | 3.66 | Cimetidine treatment of acute and chronic Zollinger-Ellison syndrome. ( Bonfils, S; Gratton, J; Mignon, M, 1979) |
| " Most of the early excess in mortality was attributable to cimetidine being given in the late stages of many diseases, often to counter adverse gastric effects of other drugs." | 1.28 | Postmarketing surveillance of the safety of cimetidine: 10 year mortality report. ( Colin-Jones, DG; Langman, MJ; Lawson, DH; Logan, RF; Paterson, KR; Vessey, MP, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (50.00) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mignon, M | 2 |
| Bonnefond, A | 1 |
| Gratton, J | 2 |
| Bonfils, S | 2 |
| Langman, MJ | 2 |
| Colin-Jones, DG | 1 |
| Lawson, DH | 1 |
| Logan, RF | 1 |
| Paterson, KR | 1 |
| Vessey, MP | 1 |
| Pisegna, JR | 1 |
| Norton, JA | 1 |
| Slimak, GG | 1 |
| Metz, DC | 1 |
| Maton, PN | 1 |
| Gardner, JD | 1 |
| Jensen, RT | 1 |
| Isobe, Y | 1 |
| Nagai, H | 1 |
| Muramatsu, M | 1 |
| Aihara, H | 1 |
| Otomo, S | 1 |
1 trial available for cimetidine and Cancer of Duodenum
| Article | Year |
|---|---|
Effects of curative gastrinoma resection on gastric secretory function and antisecretory drug requirement in the Zollinger-Ellison syndrome.
Topics: Adult; Aged; Cimetidine; Dose-Response Relationship, Drug; Duodenal Neoplasms; Famotidine; Female; F | 1992 |
5 other studies available for cimetidine and Cancer of Duodenum
| Article | Year |
|---|---|
Repeated vomiting of gastric juice in a patient with Zollinger-Ellison syndrome. Modifying influence upon clinical features.
Topics: Cimetidine; Duodenal Neoplasms; Female; Gastric Juice; Humans; Middle Aged; Paraneoplastic Endocrine | 1981 |
Cimetidine treatment of acute and chronic Zollinger-Ellison syndrome.
Topics: Acute Disease; Benzodiazepines; Chronic Disease; Cimetidine; Duodenal Neoplasms; Gastrectomy; Gastri | 1979 |
Drugs for peptic ulcer.
Topics: Antacids; Bismuth; Carbenoxolone; Chelating Agents; Cimetidine; Duodenal Neoplasms; Duodenal Ulcer; | 1979 |
Postmarketing surveillance of the safety of cimetidine: 10 year mortality report.
Topics: Cimetidine; Duodenal Neoplasms; Esophageal Neoplasms; Female; Histamine H2 Antagonists; Humans; Live | 1992 |
Antisecretory and antilesional effect of a new histamine H2-receptor antagonist, IT-066, in rats.
Topics: Animals; Cimetidine; Cold Temperature; Cysteamine; Dose-Response Relationship, Drug; Duodenal Neopla | 1990 |